• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Assay Depot launches Pfizer virtual research platform

Assay Depot launches Pfizer virtual research platform

August 16, 2013
CenterWatch Staff

Assay Depot, a provider of outsourced scientific services, has launched Market Exchange for Innovative Services (MXIS), a virtual outsourcing platform for Pfizer scientists. MXIS brings together research services from thousands of global vendors (aka CROs) into one secure website, enabling Pfizer scientists to communicate with any research vendor.

Using MXIS, Pfizer researchers can query the marketplace for services, request quotes, find and compare outsourced services, place orders, track projects and create reports. It is a centralized IT platform that enables Pfizer scientists to create, customize and purchase any research service, and to manage the sourcing project from initial request to service delivery. Researchers can access the platform from anywhere they access the Internet, including tablets and mobile devices.

"MXIS gives scientists rapid and efficient access to innovative research services from any global service provider in Assay Depot's network," said Robert Kaufman, Assay Depot's vice president of engineering. "Scientists can quickly order or custom design a research service and then work closely with their outsourcing partners, reducing the time it takes to complete a research project."

"The MXIS sourcing system fosters transparency across Pfizer's global research operations and external services," said Sylvie Sakata, Pfizer's senior director, External Research Solutions. "It's a new way to empower our scientists and strengthen relationships with our external research partners, promoting innovation across the entire Pfizer research community."

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing